John Lunger, Chief Patient Supply Officer at Adaptimmune Therapeutics PLC (ADAP), sold 1,065 shares at $5.33 ($6K) on 2021-01-04, disclosed to the SEC on 2021-01-05.
Open-market sale of $6k ADAP by Chief Patient Supply Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADAP | SELL | 2024-01-17 | $16K | — | Filing → |
| ADAP | SELL | 2024-01-12 | $8K | — | Filing → |
| ADAP | SELL | 2023-08-01 | $3K | — | Filing → |